Prostate cancer is a major health concern for men worldwide — often developing without any immediate warning signs. Catching ...

Pharma stock Theralase Technologies (TSXV:TLT) announced a significant update on its ongoing bladder cancer clinical study ...

TORONTO, ON / ACCESSWIRE / October 7, 2024 / Theralase® Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development ...

Prostate cancer is the second-most common form of the disease among men after skin cancer. There are a number of signs and ...

particularly older men. While women are often associated with bladder issues due to factors like childbirth and menopause, men are not immune to this condition, which can significantly affect ...

The subtypes investigated in bladder cancer were CK19, CK20 and CK7 IHC/RT-PCR CK20: 56–46% [98,99]; CK7: 100% [99]; CK1: 93.1% [101] Association of CK19 with UPII detected pN0 patients with ...

Northwestern raised a record $1.05 billion in research funding this fiscal year, a 5% increase since 2023. The Daily compiled ...

Erectile dysfunction. Men or people assigned male at birth who have neurogenic bladder can have problems with sexual function, including infertility. You may have trouble getting an erection ...

Whether extended lymphadenectomy is associated with improved disease-free and overall survival, as compared with standard lymphadenectomy, among patients with localized muscle-invasive bladder ...

AstraZeneca Plc’s Imfinzi extended the lives of patients with bladder cancer, potentially opening up a new market for the blockbuster medicine. In patients with muscle-invasive bladder cancer ...